Information Provided By: 
Fly News Breaks for March 19, 2019
ZTS
Mar 19, 2019 | 17:00 EDT
SunTrust analyst Gregg Gilbert initiated Zoetis with a Hold rating and a price target of $100. The analyst says the company is a "best-in-class animal health company with an attractive combination of sustainable organic growth, a diversified portfolio, low-risk R&D strategy, cash-pay model, and a leverageable infrastructure", but also believes that these attributes are reflected in its valuation. Gilbert states that he would prefer to await a "more attractive entry point."
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
